✦ LIBER ✦

Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam cooperative head and neck cancer study group

✍ Scribed by Verweij, J.; Alexieva-Figusch, J.; De Boer, M.F.; Reichgelt, B.; Stoter, G.

Book ID: 123464781
Publisher: Elsevier Science
Year: 1988
Weight: 104 KB
Volume: 24
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(88)90318-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of edatrexate in advanced

Phase II study of edatrexate in advanced head and neck cancer

✍ J. Philip Kuebler; Jacqueline Benedetti; David E. Schuller; John Ensley; Steven 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 279 KB

Phase II study of fazarabine in advanced

Phase II study of fazarabine in advanced head and neck cancer

✍ J. Philip Kuebler; Barbara Metch; David E. Schuller; Michael Keppen; Harry E. Hy 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 138 KB

Ifosfamide in advanced epidermoid head a

Ifosfamide in advanced epidermoid head and neck cancer

✍ M. Martín; E. Diaz-Rubio; J. L. González Larriba; A. Casado; J. Sastre; J. M. Ló 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 245 KB

The dutch head and neck cancer cooperati

The dutch head and neck cancer cooperative study group (NWHHT-SG)

✍ J. Langendijk 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 66 KB

A phase II study of taxotere in patients

A phase II study of taxotere in patients with advanced head and neck cancer

✍ Catimel, G; Verweij, J; Wagener, T; Piccart, M; Hanauske, AR; Franklin, H; Wande 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 178 KB

A phase II study of piritrexim in patien

A phase II study of piritrexim in patients with advanced squamous head and neck cancer

✍ Wu-Ching Uen; Andrew T. Huang; Robert Mennel; Stephen E. Jones; Monica B. Spauld 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 3 views

Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the